BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15367482)

  • 1. The challenge of secondary prevention for coronary heart disease in older patients: findings from the British Women's Heart and Health Study and the British Regional Heart Study.
    Lawlor DA; Whincup P; Emberson JR; Rees K; Walker M; Ebrahim S
    Fam Pract; 2004 Oct; 21(5):582-6. PubMed ID: 15367482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001.
    Tonstad S; Rosvold EO; Furu K; Skurtveit S
    J Intern Med; 2004 Apr; 255(4):494-502. PubMed ID: 15049884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study.
    Lawlor DA; Bedford C; Taylor M; Ebrahim S
    J Epidemiol Community Health; 2003 Feb; 57(2):134-40. PubMed ID: 12540690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular secondary prevention: patients' knowledge of cardiovascular risk factors and their attitude to reduce the risk burden, and the practice of family doctors. The "Help Your Heart Stay Young" study.
    Celentano A; Palmieri V; Arezzi E; Sabatella M; Guillaro B; Brancati C; Piccinocchi G; Minichiello S; Russo C; Pezzullo S; Tufano A; Finelli L; Panico S; Di Minno G
    Ital Heart J; 2004 Oct; 5(10):767-73. PubMed ID: 15626274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of lipid-lowering treatment according to lipid level.
    Pilote L; Ho V; Lavoie F; Coupal L; Zowall H; Grover SA
    Can J Cardiol; 2005 Jun; 21(8):681-7. PubMed ID: 16003451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study.
    Athyros VG; Kakafika AI; Papageorgiou AA; Paraskevas KI; Tziomalos K; Anagnostis P; Pagourelias E; Koumaras C; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2008 Jun; 24(6):1593-9. PubMed ID: 18430270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE.
    Palmieri L; Donfrancesco C; Giampaoli S; Trojani M; Panico S; Vanuzzo D; Pilotto L; Cesana G; Ferrario M; Chiodini P; Sega R; Stamler J
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):562-70. PubMed ID: 16874146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major coronary risk factors and death from coronary heart disease: baseline and follow-up mortality data from the Second National Health and Nutrition Examination Survey (NHANES II).
    Mensah GA; Brown DW; Croft JB; Greenlund KJ
    Am J Prev Med; 2005 Dec; 29(5 Suppl 1):68-74. PubMed ID: 16389129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.
    Mosca L; Edelman D; Mochari H; Christian AH; Paultre F; Pollin I
    J Womens Health (Larchmt); 2006; 15(1):24-34. PubMed ID: 16417415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease prevention tailored for women.
    Engberding N; Wenger NK
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1123-34. PubMed ID: 18793115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors and coronary heart disease prevention in selected Lódź population--Part I].
    Kowalski J; Gburek J; Kos M; Wrocławski W; Pawlicki L
    Pol Merkur Lekarski; 2005 Dec; 19(114):743-8. PubMed ID: 16521414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention for the older woman. A practical guide to managing cardiovascular disease.
    Messinger-Rapport BJ; Thacker HL
    Geriatrics; 2002 Jul; 57(7):22-6, 29-30. PubMed ID: 12134461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary heart disease risk in men and the epidemic of overweight and obesity.
    Nanchahal K; Morris JN; Sullivan LM; Wilson PW
    Int J Obes (Lond); 2005 Mar; 29(3):317-23. PubMed ID: 15597108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.
    Greving JP; Buskens E; Koffijberg H; Algra A
    Circulation; 2008 Jun; 117(22):2875-83. PubMed ID: 18506010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration.
    Blanco-Colio LM; Martín-Ventura JL; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Martineau P; Egido J;
    Am Heart J; 2007 May; 153(5):881-8. PubMed ID: 17452168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.